Neurology and Neurosurgery

Episodes 1-16 of 44

• 

  RestartResume

  Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF 

  RestartResume

  Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF 

  CME/CE Broadcast Replay

  Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF 

  1.50 credits

  • 

    

    M. Edip Gurol, MD, MSc

  • 

    

    Robin Novakovic, MD

  • 

    

    Shadi Yaghi, MD

  • 

    

    Jeffrey Weitz, MD

  1.50 credits

• 

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  RestartResume

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  MinuteCE®

  Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  MinuteCE®

  Decoding CIDP: Exploring Common and Atypical Variants

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  1.00 credit 10 episodes

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 credit 10 episodes

• 

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  MinuteCE®

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  MinuteCE®

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  1.00 program credit

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  MinuteCE®

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  1.00 program credit

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  RestartResume

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  MinuteCE®

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  1.25 program credits

  • 

    

    C. Brendan Montano, MD

  • 

    

    Anton P. Porsteinsson, MD

  1.25 program credits

• 

  RestartResume

  Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review

  RestartResume

  Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review

  CME/CE

  Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review

  0.25 credits

  • 

    

    C. Brendan Montano, MD

  • 

    

    Anton P. Porsteinsson, MD

  0.25 credits

• 

  RestartResume

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  RestartResume

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  MinuteCE®

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  1.25 program credits

  • 

    

    C. Brendan Montano, MD

  • 

    

    Anton P. Porsteinsson, MD

  1.25 program credits

• 

  MinuteCE®

  Optimizing Outcomes in AAD in Community PCP and LTC Clinics

  1.25 credits 11 episodes

  • 

    

    C. Brendan Montano, MD

  • 

    

    Anton P. Porsteinsson, MD

  1.25 credits 11 episodes